Small-Molecule Drugs
Sildenafil
Last reviewed: 2026-11-19
Evidence status & limitations
Product-specific erectile-dysfunction and pulmonary-hypertension indications are distinct.
Regulatory status
FDA approval applies only to the named products and indications below. It does not approve every formulation or other use.
Viagra · Sexual Health
Erectile dysfunction in the labeled adult population.
Authoritative label recordRevatio · Pulmonary Arterial Hypertension
Pulmonary arterial hypertension under product-specific labeled conditions.
Authoritative label record
Status as of 2026-11-19. Regulations change. Check FDA.gov for current information.
WADA prohibited status: current list and contextKnown risks & open questions
Dangerous nitrate interactions, hypotension and rare vision or hearing events are documented.
Key sources
Indication-specific regulatory sources and editorial screen checked November 19, 2026. This is not an exhaustive systematic review; consult current labels.
Related compounds
- Apomorphine
Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications
- Finasteride
Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications
- Metformin
Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications
- Methylthioninium chloride
Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications
- Minoxidil
Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications